124 related articles for article (PubMed ID: 26212547)
1. Pharmacological induction of mitochondrial biogenesis as a therapeutic strategy for the treatment of type 2 diabetes.
Zamora M; Pardo R; Villena JA
Biochem Pharmacol; 2015 Nov; 98(1):16-28. PubMed ID: 26212547
[TBL] [Abstract][Full Text] [Related]
2. Enhanced autophagy plays a cardinal role in mitochondrial dysfunction in type 2 diabetic Goto-Kakizaki (GK) rats: ameliorating effects of (-)-epigallocatechin-3-gallate.
Yan J; Feng Z; Liu J; Shen W; Wang Y; Wertz K; Weber P; Long J; Liu J
J Nutr Biochem; 2012 Jul; 23(7):716-24. PubMed ID: 21820301
[TBL] [Abstract][Full Text] [Related]
3. Perspectives and potential applications of mitochondria-targeted antioxidants in cardiometabolic diseases and type 2 diabetes.
Rocha M; Apostolova N; Herance JR; Rovira-Llopis S; Hernandez-Mijares A; Victor VM
Med Res Rev; 2014 Jan; 34(1):160-89. PubMed ID: 23650093
[TBL] [Abstract][Full Text] [Related]
4. Targeting mitochondrial biogenesis to treat insulin resistance.
Zamora M; Villena JA
Curr Pharm Des; 2014; 20(35):5527-57. PubMed ID: 24606798
[TBL] [Abstract][Full Text] [Related]
5. Relationships between exercise, mitochondrial biogenesis and type 2 diabetes.
Joseph AM; Hood DA
Med Sport Sci; 2014; 60():48-61. PubMed ID: 25226800
[TBL] [Abstract][Full Text] [Related]
6. Protection of pancreatic beta-cells: is it feasible?
Bonora E
Nutr Metab Cardiovasc Dis; 2008 Jan; 18(1):74-83. PubMed ID: 18096375
[TBL] [Abstract][Full Text] [Related]
7. Pioglitazone ameliorates the lowered exercise capacity and impaired mitochondrial function of the skeletal muscle in type 2 diabetic mice.
Takada S; Hirabayashi K; Kinugawa S; Yokota T; Matsushima S; Suga T; Kadoguchi T; Fukushima A; Homma T; Mizushima W; Masaki Y; Furihata T; Katsuyama R; Okita K; Tsutsui H
Eur J Pharmacol; 2014 Oct; 740():690-6. PubMed ID: 24964389
[TBL] [Abstract][Full Text] [Related]
8. Targeting Mitochondria in Diabetes.
Krako Jakovljevic N; Pavlovic K; Jotic A; Lalic K; Stoiljkovic M; Lukic L; Milicic T; Macesic M; Stanarcic Gajovic J; Lalic NM
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34205752
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial dysfunction in diabetes and the regulatory roles of antidiabetic agents on the mitochondrial function.
Yaribeygi H; Atkin SL; Sahebkar A
J Cell Physiol; 2019 Jun; 234(6):8402-8410. PubMed ID: 30417488
[TBL] [Abstract][Full Text] [Related]
10. Muscle mitochondria and insulin resistance: a human perspective.
Hoeks J; Schrauwen P
Trends Endocrinol Metab; 2012 Sep; 23(9):444-50. PubMed ID: 22726362
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial dysfunction leads to impairment of insulin sensitivity and adiponectin secretion in adipocytes.
Wang CH; Wang CC; Huang HC; Wei YH
FEBS J; 2013 Feb; 280(4):1039-50. PubMed ID: 23253816
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial dysfunction in type 2 diabetes and obesity.
Højlund K; Mogensen M; Sahlin K; Beck-Nielsen H
Endocrinol Metab Clin North Am; 2008 Sep; 37(3):713-31, x. PubMed ID: 18775360
[TBL] [Abstract][Full Text] [Related]
13. A novel MitoNEET ligand, TT01001, improves diabetes and ameliorates mitochondrial function in db/db mice.
Takahashi T; Yamamoto M; Amikura K; Kato K; Serizawa T; Serizawa K; Akazawa D; Aoki T; Kawai K; Ogasawara E; Hayashi J; Nakada K; Kainoh M
J Pharmacol Exp Ther; 2015 Feb; 352(2):338-45. PubMed ID: 25503385
[TBL] [Abstract][Full Text] [Related]
14. Hypoglycemic pharmacological treatment of type 2 diabetes: targeting the endothelium.
Nathanson D; Nyström T
Mol Cell Endocrinol; 2009 Jan; 297(1-2):112-26. PubMed ID: 19038307
[TBL] [Abstract][Full Text] [Related]
15. Adipose mitochondrial biogenesis is suppressed in db/db and high-fat diet-fed mice and improved by rosiglitazone.
Rong JX; Qiu Y; Hansen MK; Zhu L; Zhang V; Xie M; Okamoto Y; Mattie MD; Higashiyama H; Asano S; Strum JC; Ryan TE
Diabetes; 2007 Jul; 56(7):1751-60. PubMed ID: 17456854
[TBL] [Abstract][Full Text] [Related]
16. Targeting mitochondrial biogenesis for preventing and treating insulin resistance in diabetes and obesity: Hope from natural mitochondrial nutrients.
Liu J; Shen W; Zhao B; Wang Y; Wertz K; Weber P; Zhang P
Adv Drug Deliv Rev; 2009 Nov; 61(14):1343-52. PubMed ID: 19716392
[TBL] [Abstract][Full Text] [Related]
17. The potential of therapeutic strategies targeting mitochondrial biogenesis for the treatment of insulin resistance and type 2 diabetes mellitus.
Ding W; Yang X; Lai K; Jiang Y; Liu Y
Arch Pharm Res; 2024 Mar; 47(3):219-248. PubMed ID: 38485900
[TBL] [Abstract][Full Text] [Related]
18. Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress.
Rolo AP; Palmeira CM
Toxicol Appl Pharmacol; 2006 Apr; 212(2):167-78. PubMed ID: 16490224
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial function in skeletal muscle in type 2 diabetes.
Rabøl R
Dan Med Bull; 2011 Apr; 58(4):B4272. PubMed ID: 21466770
[TBL] [Abstract][Full Text] [Related]
20. The insulin-sensitizing effect of rosiglitazone in type 2 diabetes mellitus patients does not require improved in vivo muscle mitochondrial function.
Schrauwen-Hinderling VB; Mensink M; Hesselink MK; Sels JP; Kooi ME; Schrauwen P
J Clin Endocrinol Metab; 2008 Jul; 93(7):2917-21. PubMed ID: 18460571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
